Antibody screening has enjoyed considerable success in finding antibodies that can grasp disease-associated targets and contribute to therapeutic applications. For example, since the mid-1980s, ...

Testing industry include rising autoimmune disease cases boosting demand, technological advances enhancing diagnostics, and supportive policies increasing access. Fast-growing regions like ...

Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company ...

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization ...

A coalition of U.K. research institutions and diagnostic developers backed by the British government has secured regulatory clearance to move ahead with their hand-held antibody blood test for ...

LAWRENCE -- A paper just published in Nature Biotechnology outlines a pioneering method of screening a person's diverse set of antibodies for rapid therapeutic discovery. Antibody proteins are an ...

As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus.

GlobalBio’s validated, highly diverse human antibody libraries are now available pre-integrated into Neochromosome’s novel neoSwitch™ yeast strain.

KILGORE, Texas (KLTV) - Many people have now been tested for COVID-19, but have not been screened for antibodies, which people can develop to help fight the disease. At Christus Good Shepherd Kilgore ...

To the editor: Thank you for a front-page article on the screening we most need — serologic testing of a well chosen sample of a population exposed to the coronavirus. This is the kind of testing that ...